Q4 2024 Enovis Corp Earnings Call Transcript
Key Points
- Enovis Corp (ENOV) reported a 23% growth in the fourth quarter of 2024, with a 7% increase on a constant currency comparable basis.
- The company successfully integrated Lima, exceeding all year one goals and contributing to a 210 basis point expansion in adjusted EBITDA margins.
- Recon segment delivered 59% reported global revenue growth, with double-digit growth in both Hip Knee and Extremities segments.
- Fourth quarter adjusted gross margin improved by 150 basis points year-over-year, driven by favorable segment mix and Lima cost initiatives.
- Enovis Corp (ENOV) expects strong execution in 2025 with projected revenues between $2.19 billion to $2.22 billion, and adjusted EBITDA in the range of $405 million to $415 million.
- Enovis Corp (ENOV) recorded a noncash technical impairment of goodwill amounting to $645 million due to a sustained decrease in share price and market capitalization.
- Interest expense increased to $9 million in the fourth quarter compared to $4 million in 2023.
- The company anticipates negative currency headwinds of approximately 1% to 2% in 2025.
- Potential tariff impacts from China and Mexico could represent a $3 million to $4 million exposure per month, which is not included in the 2025 guidance.
- The company is still managing integration headwinds from the Lima acquisition, which affected US recon growth.
Good day, and welcome to the Innovus fourth quarter 2024 earnings conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Kyle Rose, Vice President of Investor Relations. Please go ahead.
Thank you, Danielle. Good morning, everyone, and thank you for joining us today for our fourth quarter 2024 results conference call. I'm Kyle Rose, Vice President of Investor Relations. Joining me on the call this morning are Matthew Trerotola, Chair and Chief Executive Officer; and Ben Berry, Chief Financial Officer. Our earnings release was issued earlier this morning and is available in the Investor Relations section of our website enovis.com. We will be using a slide presentation in today's call, which can also be found on our website. Both the audio and the slide presentation of this call will be archived on the website later today.
During this call, we'll be making some forward-looking statements about our beliefs and estimates regarding future
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
